mRNA Flu Vaccine Gets FDA Approval But Safety Data Shows “Higher Observed Death” Says Dr. Jessica Rose w/ Dr. Kelly Victory & Peter Gillooly – Ask Dr. Drew – Ep 655

mRNA Flu Vaccine Gets FDA Approval But Safety Data Shows “Higher Observed Death” Says Dr. Jessica Rose w/ Dr. Kelly Victory & Peter Gillooly – Ask Dr. Drew – Ep 655

August 15, 2026 · 1h 20m · Season 1 · Episode 655

About this episode

The episode discusses the FDA's approval of the mRNA flu vaccine and concerns about its safety data.

The FDA has approved the first mRNA flu shot: Moderna’s mFlusiva – but immunologist Dr. Jessica Rose says it safety tests are flawed. “… You will find the safety data that definitively shows that more people died in the context of the mRNA-1010 injectable product than in the comparator group,” writes Dr. Rose. “You should know that the comparator group ALSO were given a flu vaccine – NOT A SALINE PLACEBO.” Reuters reports the approval covers adults 50 and older, based on a late-stage trial of more than 40,000 people that showed the shot was 26.6% more effective than a licensed standard-dose flu vaccine. But Dr. Rose says that no saline placebo was used, and the comparator group also received a flu vaccine – and that the data she’s seen indicates high adverse reactions to the new shots. Dr. Kelly Victory, Chief of Emergency & Disaster Medicine at The Wellness Company, joins Wellness Company CEO Peter Gillooly to discuss RFK’s push to split the childhood MMR vaccine into separate shots, new releases from Dr. Fauci’s pandemic text messages, and TWC’s research on Alpha-Gal. Dr. Jessica Rose is a Canadian researcher with a Bachelor’s in Applied Mathematics and a…

More episodes of Ask Dr. Drew

Explore listener stats, chart rankings, contacts and more on the Ask Dr. Drew podcast page.